Improved in vitro biocompatibility of surface-modified hydroxyapatite sponge scaffold with gelatin and BMP-2 in comparison against a commercial bone allograft

ASAIO Journal

Volumn 61, Issue 1, 2015, Pages 78-86

  Carpena, Nathaniel T ^a,b   Min, Young Ki ^b,c   Lee, Byong Taek ^a,c  

^a InoBone ^*  (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

allograft; biomaterials; bone regeneration; growth factor

Indexed keywords

BIOCOMPATIBILITY; BONE; CELL ADHESION; COMPRESSIVE STRENGTH; HYDROXYAPATITE; PORE SIZE;

BONE ALLOGRAFTS; CELL VIABILITY; GROWTH FACTOR; IN-VITRO; MC3T3-E1 CELL; REPLICA METHOD; SURFACE AREA; SURFACE-MODIFIED;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; GELATIN; HYDROXYAPATITE; BIOMATERIAL; BMP2 PROTEIN, HUMAN; BONE PROSTHESIS; RECOMBINANT PROTEIN;

ARTICLE; BIOCOMPATIBILITY; BIOMECHANICS; BONE PROSTHESIS; CADAVER; CELL ADHESION; CELL PROLIFERATION; CELL VIABILITY; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DEMINERALIZED FREEZE DRIED BONE ALLOGRAFT; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MATERIALS TESTING; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE MODIFIED HYDROXYAPATITE SPONGE SCAFFOLD; TISSUE SCAFFOLD; 3T3 CELL LINE; ALLOGRAFT; ANIMAL; BONE TRANSPLANTATION; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; MOUSE; OSTEOBLAST;

3T3 CELLS; ALLOGRAFTS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE SUBSTITUTES; BONE TRANSPLANTATION; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; COMPRESSIVE STRENGTH; DURAPATITE; GELATIN; HUMANS; IN VITRO TECHNIQUES; MATERIALS TESTING; MICE; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; POROSITY; RECOMBINANT PROTEINS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE SCAFFOLDS;

EID: 84929045350     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000155     Document Type: Article

References (52)

1. Bhandari M, Jain AK. Bone stimulators: Beyond the black box. Indian J Orthop 43: 109-110, 2009
2. Blokhuis TJ, Arts JJ. Bioactive and osteoinductive bone graft substitutes: Definitions, facts and myths. Injury 42 (suppl 2): S26-S29, 2011
3. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 84-A: 454-464, 2002
4. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN. American Academy of Orthopaedic Surgeons. The Committee on Biological Implants: Bone-graft substitutes: Facts, fictions, and applications. J Bone Joint Surg Am 83-A (suppl 2 Pt 2): 98-103, 2001
5. Arrington ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329: 300-309, 1996
6. R obertson PA, Wray AC. Natural history of posterior iliac crest bone graft donation for spinal surgery: A prospective analysis of morbidity. Spine (Phila Pa 1976) 26: 1473-1476, 2001
7. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 3: 192-195, 1989
8. Urist MR. Bone: Formation by autoinduction. Science (New York, N.Y.) 150: 893-899, 1965
9. Urist MR, Peltier LF. Bone: Formation by autoinduction. Clin Orthop Relat Res 395: 4-10, 2002
10. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528-1534, 1988
11. Bae HW, Zhao L, Kanim LE, Wong P, Delamarter RB, Dawson EG. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products. Spine (Phila Pa 1976) 31: 1299-306, 2006
12. Drosos GI, Kazakos KI, Kouzoumpasis P, Verettas DA. Safety and efficacy of commercially available demineralised bone matrix preparations: A critical review of clinical studies. Injury 38 (suppl 4): S13-S21, 2007
13. Takata M, Sugimoto N, Yamamoto N, et al. Activity of bone morphogenetic protein-7 after treatment at various temperatures: Freezing vs. pasteurization vs. allograft. Cryobiology 63: 235-239, 2011
14. Oonishi H. Orthopaedic applications of hydroxyapatite. Biomaterials 12: 171-178, 1991
15. R oy DM, Linnehan SK. Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange. Nature 247: 220-222, 1974
16. Chang MC, Ikoma T, Kikuchi M, et al. Preparation of a porous hydroxyapatite/collagen nanocomposite using glutaraldehyde as a crosslinkage agent. J Mater Sci 20: 1199-1201, 2001
17. Wang X, Li Y, Wei J, de Groot K. Development of biomimetic nano-hydroxyapatite/poly(hexamethylene adipamide) composites. Biomaterials 23: 4787-4791, 2002
18. Hulbert SF, Morrison SJ, Klawitter JJ. Tissue reaction to three ceramics of porous and non-porous structures. J Biomed Mater Res 6: 347-374, 1972
19. Dubruel P, Unger R, Vlierberghe SV, et al. Porous gelatin hydrogels: 2. In vitro cell interaction study. Biomacromolecules 8: 338-344, 2007
20. Weng L, Pan H, Chen W. Self-crosslinkable hydrogels composed of partially oxidized hyaluronan and gelatin: In vitro and in vivo responses. J Biomed Mater Res A 85: 352-365, 2008
21. Tabata Y, Nagano A, Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5: 127-138, 1999
22. Kimura Y, Ozeki M, Inamoto T, Tabata Y. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24: 2513-2521, 2003
23. Ogawa T, Akazawa T, Tabata Y. In vitro proliferation and chondrogenic differentiation of rat bone marrow stem cells cultured with gelatin hydrogel microspheres for TGF-1 release. J Biomater Sci Polym Ed 21: 609-621, 2010
24. Chen J-P, Chang F-N: Preparation and characterization of hydroxyapatite/gelatin composite membranes for immunoisolation. Appl Surf Sci 262: 176-183, 2012
25. Kailasanathan C, Selvakumar N, Naidu V. Structure and properties of titania reinforced nano-hydroxyapatite/gelatin bio-composites for bone graft materials. Ceram Int 38: 571-579, 2012
26. Yamamoto M, Ikada Y, Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12: 77-88, 2001
27. Yamamoto M, Tabata Y, Hong L, et al. Bone regeneration by transforming growth factor β1 released from a biodegradable hydrogel. J Controlled Release 64: 133-142, 2000
28. Patel ZS, Yamamoto M, Ueda H, Tabata Y, Mikos AG. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater 4: 1126-1138, 2008
29. Yamamoto M, Takahashi Y, Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24: 4375-4383, 2003
30. Srouji S, Rachmiel A, Blumenfeld I, et al. Mandibular defect repair by TGF-β and IGF-1 released from a biodegradable osteoconductive hydrogel. J Craniomaxillofac Surg 33: 79-84, 2005
31. Tabata Y, Hijikata S, Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Controlled Release 31: 189-199, 1994
32. Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10: 79-94, 1999
33. Adhirajan N, Shanmugasundaram N, Babu M. Gelatin microspheres cross-linked with EDC as a drug delivery system for doxycyline: Development and characterization. J Microencapsul 24: 647-659, 2007
34. Bostrom MP, Seigerman DA. The clinical use of allografts, demineralized bone matrices, synthetic bone graft substitutes and osteoinductive growth factors: A survey study. HSS J 1: 9-18, 2005
35. Zimmermann G, Moghaddam A. Allograft bone matrix versus synthetic bone graft substitutes. Injury 42 (suppl 2): S16-S21, 2011
36. Han J-K, Song H-Y, Saito F, et al. Synthesis of high purity nanosized hydroxyapatite powder by microwave-hydrothermal method. Mater Chem Phys 99: 235-239, 2006
37. Kim M-S, Jang D-W, Min Y-K, et al. Fabrication of bone substitutes by the sponge replica method. Mater Sci Forum 654-656: 2245-2248, 2010
38. Habibovic P, de Groot K. Osteoinductive biomaterials-Properties and relevance in bone repair. J Tissue Eng Regen Med 1: 25-32, 2007
39. Bignon A, Chouteau J, Chevalier J, et al. Effect of micro- and macroporosity of bone substitutes on their mechanical properties and cellular response. J Mater Sci Mater Med 14: 1089-1097, 2003
40. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21: 2529-2543, 2000
41. Chen M, Tan J, Lian Y, et al. Preparation of Gelatin coated hydroxyapatite nanorods and the stability of its aqueous colloidal. Appl Surf Sci 254: 2730-2735, 2008
42. Hong Z, Zhang P, He C, et al. Nano-composite of poly(l-lactide) and surface grafted hydroxyapatite: Mechanical properties and biocompatibility. Biomaterials 26: 6296-6304, 2005
43. Wildemann B, Kadow-Romacker A, Haas NP, et al. Quantification of various growth factors in different demineralized bone matrix preparations. J Biomed Mater Res A 81(2): 437-442, 2006
44. Adhirajan N, Shanmugasundaram N, Shanmuganathan S, Babu M. Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth. Eur J Pharm Sci 36: 235-245, 2009
45. He X, Liu Y, Yuan X, Lu L. Enhanced healing of rat calvarial defects with MSCs loaded on BMP-2 releasing chitosan/alginate/hydroxyapatite scaffolds. PLoS One 9: e104061, 2014
46. Hussain A, Takahashi K, Sonobe J, Tabata Y, Bessho K. Bone regeneration of rat calvarial defect by magnesium calcium phosphate gelatin scaffolds with or without bone morphogenetic protein- 2. J Maxillofac Oral Surg 13: 29-35, 2014
47. L iu H, Peng H, Wu Y, et al. The promotion of bone regeneration by nanofibrous hydroxyapatite/chitosan scaffolds by effects on integrin-BMP/Smad signaling pathway in BMSCs. Biomaterials 34: 4404-4417, 2013
48. Notodihardjo FZ, Kakudo N, Kushida S, Suzuki K, Kusumoto K. Bone regeneration with BMP-2 and hydroxyapatite in criticalsize calvarial defects in rats. J Craniomaxillofac Surg 40: 287-291, 2012
49. Omata K, Matsuno T, Asano K, et al. Enhanced bone regeneration by gelatin-β-tricalcium phosphate composites enabling controlled release of bFGF. J Tissue Eng Regen Med 8: 604-611, 2014
50. Magne D, Bluteau G, Faucheux C, et al. Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: Possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res 18: 1430-1442, 2003
51. Washburn NR, Yamada KM, Simon CG Jr, Kennedy SB, Amis EJ. High-throughput investigation of osteoblast response to polymer crystallinity: Influence of nanometer-scale roughness on proliferation. Biomaterials 25: 1215-1224, 2004
52. Sastry SK, Burridge K. Focal adhesions: A nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 261: 25-36, 2000